Search

Joan W. Miller, MD, has been appointed to the Association of University Professors of Ophthalmology (AUPO) Board of Trustees. As Chair of Harvard Ophthalmology since 2003, Dr. Miller is committed driving innovation and quality in academic medicine, and strongly supports mentoring and developing...

In March 2017, Michael Gilmore, PhD, Director of the Harvard Infectious Disease Institute, chaired a blue ribbon panel that reviewed the most promising applications for the Antimicrobial Resistance Diagnostic Challenge--a $20 million federal prize competition to develop innovative, rapid point-of...

After seven years, multi-center clinical trial finds systemic therapy better preserves visual acuity and has fewer side effects Boston, Mass. — Systemic therapy consisting of corticosteroids and immunosuppressants preserved vision of uveitis patients better – and had fewer adverse outcomes – than a...

Eli Peli, MSc, OD, has joined the board for directors of ITN America. This non-profit provides ride services for the elderly and visually impaired. They support sustainable, community-based transportation services for seniors throughout the world by building a senior transportation network through...

Prestigious award honors outstanding research in ophthalmology Boston, Mass. — The Association for Research in Vision and Ophthalmology (ARVO) recently announced that Reza Dana, MD, MPH, MSc, Director of Cornea and Refractive Surgery at Massachusetts Eye and Ear and a resident of Newton, Mass., will...

Research Grant Awarded to Dr. Brian J. Song, Massachusetts Eye and Ear Infirmary, and Department of Ophthalmology at Harvard Medical School CHICAGO (June 5, 2017) – Prevent Blindness , the nation’s oldest volunteer eye health and safety organization, announced today the recipient of its 2017 Joanne...

In February 2016, Reza Dana, MD, MPH, MSc, Vice Chair for Academic Programs for the Harvard Medical School (HMS) Department of Ophthalmology, and Director of the Cornea and Refractive Surgery Service at Massachusetts Eye and Ear, was elected to Academia Ophthalmologica Internationalis (AOI), one of...

Findings could eventually lead to first non-surgical therapies and treatments for FECD. BOSTON -- Researchers at Schepens Eye Research Institute of Massachusetts Eye and Ear have shown a link between mitochondrial dysfunction in corneal endothelial cells and the development of Fuchs’ Endothelial...

A complication associated with bone marrow transplantation, graft-versus-host-disease occurs when a transplanted immune system attacks certain parts of a host’s body, and may cause severe dry eye and damage to the cornea. A clinical trial at Massachusetts Eye and Ear showed that topical doses of...

Selecta is licensing Anc80 from Massachusetts Eye and Ear for a rare genetic disease with options on additional pre-specified indications. By combining Anc80 with Selecta’s investigational drug candidate, SVP-Rapamycin (SEL-110), Selecta is seeking to advance a new gene therapy platform designed to...